A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2

Clinical trial NCT06555783 · COMPLETED

Trial details

NCT number: NCT06555783
Sponsor: Alkermes, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Narcolepsy Type 2

Start date: 2024-07-26
Primary completion: 2025-11-11
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.